Cargando…

Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations

Cigarette smoking is one of the most significant public health issues and the most common environmental cause of preventable cancer deaths worldwide. EGFR (Epidermal Growth Factor Receptor)-targeted therapy has been used in the treatment of LC (lung cancer), mainly caused by the carcinogens in cigar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yilmaz, Ahmet, Mohamed, Nehad, Patterson, Kara A., Tang, Yan, Shilo, Konstantin, Villalona-Calero, Miguel A., Davis, Michael E., Zhou, Xiaoping, Frankel, Wendy, Otterson, Gregory A., Beall, Howard D., Zhao, Weiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199031/ https://www.ncbi.nlm.nih.gov/pubmed/25222473 http://dx.doi.org/10.3390/ijerph110909491

Ejemplares similares

Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014)

Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer
por: Zhao, Weiqiang, et al.
Publicado: (2012)

A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation
por: Shaker, Nada, et al.
Publicado: (2023)

Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors
por: Shilo, Konstantin, et al.
Publicado: (2013)

Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations
por: Burkart, Jarred, et al.
Publicado: (2015)

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
por: Duan, Wenrui, et al.
Publicado: (2014)

Overexpression of Rad51C splice variants in colorectal tumors
por: Kalvala, Arjun, et al.
Publicado: (2014)

Survivin knockdown induces senescence in TTF-1-expressing, KRAS-mutant lung adenocarcinomas
por: Sumi, Toshiyuki, et al.
Publicado: (2018)

Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary)
por: Osman, Nisreen Abdel Tawab Abdel Gaber, et al.
Publicado: (2015)

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.
por: Ross, D., et al.
Publicado: (1996)

Redox modulation of NQO1
por: Siegel, David, et al.
Publicado: (2018)

Rad51C-ATXN7 fusion gene expression in colorectal tumors
por: Kalvala, Arjun, et al.
Publicado: (2016)

Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary
por: Palma, Norma A., et al.
Publicado: (2014)

Expression of a Mutant p53 Results in an Age-Related Demographic Shift in Spontaneous Lung Tumor Formation in Transgenic Mice
por: Duan, Wenrui, et al.
Publicado: (2009)

Implications of NQO1 in cancer therapy
por: Oh, Eun-Taex, et al.
Publicado: (2015)

The Role of NQO1 in Ovarian Cancer
por: Tossetta, Giovanni, et al.
Publicado: (2023)

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With None–Small-cell Lung Cancer
por: Owen, Dwight H., et al.
Publicado: (2018)

Activation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphane
por: Wu, Joseph M., et al.
Publicado: (2016)

Antimalarial Properties of Dunnione Derivatives as NQO2 Substrates
por: Chhour, Monivan, et al.
Publicado: (2019)

NQO1 protects against clioquinol toxicity
por: Chhetri, Jamuna, et al.
Publicado: (2022)

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005)

Short-term Exposure to 50-Hz Electromagnetic Field and Alterations in NQO1 and NQO2 Expression in MCF-7 Cells
por: Mahmoudinasab, Hamideh, et al.
Publicado: (2016)

Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1
por: Salido, Eduardo, et al.
Publicado: (2022)

Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound
por: Giovannucci, Tatiana A., et al.
Publicado: (2021)

NQO1 Binds and Supports SIRT1 Function
por: Tsvetkov, Peter, et al.
Publicado: (2021)

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis
por: He, Hairong, et al.
Publicado: (2017)

LncRNA Nqo1-AS1 Attenuates Cigarette Smoke-Induced Oxidative Stress by Upregulating its Natural Antisense Transcript Nqo1
por: Zhang, Haiyun, et al.
Publicado: (2021)

Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome
por: Fangusaro, J R, et al.
Publicado: (2005)

Survivin 2α: a novel Survivin splice variant expressed in human malignancies
por: Caldas, Hugo, et al.
Publicado: (2005)

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib()()()
por: Cuneo, Kyle C., et al.
Publicado: (2018)

KRAS and MET in non-small-cell lung cancer: two of the new kids on the ‘drivers’ block
por: Garcia-Robledo, Juan Esteban, et al.
Publicado: (2022)

MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis
por: Lu, Daniel, et al.
Publicado: (2022)

Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
por: Wang, Jieqiong, et al.
Publicado: (2016)

Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment
por: Kim, H-J, et al.
Publicado: (2014)

Papillary fibroelastoma arising from the coumadin ridge
por: Malik, Mahim, et al.
Publicado: (2017)

A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone
por: Pidugu, Lakshmi Swarna Mukhi, et al.
Publicado: (2016)

Survivin the battle against immunosuppression
por: Manuel, Edwin R., et al.
Publicado: (2012)

The twisted survivin connection to angiogenesis
por: Sanhueza, C., et al.
Publicado: (2015)

Clinical implications of high NQO1 expression in breast cancers
por: Yang, Yang, et al.
Publicado: (2014)

Pharmacokinetic and safety evaluation of MB12066, an NQO1 substrate
por: Lee, Hae Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ql9pv6so5f15afl5k3tcbts7as